Data / Form D filings / Lindy Biosciences, Inc.
Lindy Biosciences, Inc.: Form D filings
Lindy Biosciences, Inc., a biotechnology company in Morrisville, NC, filed 4 Form D notices with the SEC between 2018 and 2024. The latest, on March 19, 2024, reports $1.7 million sold of a $2.5 million offering to 10 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 627 Davis Drive, Suite 400, Morrisville, NC, 27560
- Phone
- (919) 765-8700
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1731038
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 19, 2024 | New notice | $2,500,000 | $1,709,637 | $790,363 | 10 | Mar 12, 2024 | sec.gov |
| Mar 16, 2022 | New notice | $5,000,000 | $3,259,946 | $1,740,054 | 29 | Mar 11, 2022 | sec.gov |
| Jan 22, 2019 | New notice | $1,602,734 | $547,736 | $1,054,998 | 6 | Jan 11, 2019 | sec.gov |
| Mar 16, 2018 | New notice | $150,000 | $150,000 | 1 | Mar 6, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Karen LeVert | Director | |
| Omar Flores | Executive Officer, Director | |
| Deborah Bitterfield | Executive Officer, Director, Promoter | |
| Joel Whitley | Director |
Other biotechnology companies in North Carolina that filed recently
- Toggle Bio $200,000 · Oct 6, 2026
- Swift Cardiovascular, Inc. $810,000 · Sep 24, 2026
- Aclarity Genomics, Inc. $4.6 million · Sep 2, 2026
- Aer Therapeutics, Inc. $3 million · Aug 19, 2026
Every Form D from the week of Mar 18, 2024 · All recent filings in North Carolina · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Lindy Biosciences, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.